Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of salivary gland tumors.
Andry G, Hamoir M, Locati LD, Licitra L, Langendijk JA. Andry G, et al. Expert Rev Anticancer Ther. 2012 Sep;12(9):1161-8. doi: 10.1586/era.12.92. Expert Rev Anticancer Ther. 2012. PMID: 23098116 Review.
[Tumors of the submaxillary gland].
Hamoir M, Lawson G, Andry G, Lothaire P, Sacre R, Remacle M, Fossion E. Hamoir M, et al. Among authors: andry g. Ann Otolaryngol Chir Cervicofac. 1991;108(1):26-9. Ann Otolaryngol Chir Cervicofac. 1991. PMID: 1850212 Review. French.
Parapharyngeal metastases from thyroid cancer.
Desuter G, Lonneux M, Plouin-Gaudon I, Jamar F, Coche E, Weynand B, Rahier J, Grégoire V, Andry G, Hamoir M. Desuter G, et al. Among authors: andry g. Eur J Surg Oncol. 2004 Feb;30(1):80-4. doi: 10.1016/j.ejso.2003.10.004. Eur J Surg Oncol. 2004. PMID: 14736528
Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.
Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA; EORTC Head and Neck Cancer Group. Lefebvre JL, et al. Among authors: andry g. Ann Oncol. 2012 Oct;23(10):2708-2714. doi: 10.1093/annonc/mds065. Epub 2012 Apr 6. Ann Oncol. 2012. PMID: 22492697 Free PMC article. Clinical Trial.
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.
Digonnet A, Hamoir M, Andry G, Haigentz M Jr, Takes RP, Silver CE, Hartl DM, Strojan P, Rinaldo A, de Bree R, Dietz A, Grégoire V, Paleri V, Langendijk JA, Vander Poorten V, Hinni ML, Rodrigo JP, Suárez C, Mendenhall WM, Werner JA, Genden EM, Ferlito A. Digonnet A, et al. Among authors: andry g. Eur Arch Otorhinolaryngol. 2013 May;270(5):1569-80. doi: 10.1007/s00405-012-2172-7. Epub 2012 Sep 13. Eur Arch Otorhinolaryngol. 2013. PMID: 22972497 Review.
EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.
Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk JA, Vermorken JB. Lalami Y, et al. Among authors: andry g. Radiother Oncol. 2012 Nov;105(2):238-40. doi: 10.1016/j.radonc.2012.08.006. Epub 2012 Sep 16. Radiother Oncol. 2012. PMID: 22989664 Clinical Trial.
130 results